Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COCH Envoy Medical	$1.42 -2.7%	$1.50	$1.21 ▼ $3.99	$30.56M	2.21	14,727 shs	57,200 shs
ICAD icad	$3.87	$3.82	$1.19 ▼ $4.02	$106.31M	1.37	426,282 shs	N/A
LUCD Lucid Diagnostics	$1.02 +4.0%	$1.12	$0.73 ▼ $1.80	$110.65M	1.21	703,492 shs	758,976 shs
MBOT Microbot Medical	$3.09 -1.3%	$2.63	$0.82 ▼ $3.38	$140.74M	1.15	2.39 million shs	1.72 million shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
COCH Envoy Medical	0.00%	-7.19%	-16.47%	-15.48%	-48.55%
ICAD icad	0.00%	0.00%	-0.13%	-3.01%	+176.43%
LUCD Lucid Diagnostics	0.00%	+2.35%	-10.53%	-19.05%	+23.68%
MBOT Microbot Medical	0.00%	0.00%	+22.62%	+15.30%	+212.12%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
COCH Envoy Medical	3.4667 of 5 stars	3.5	5.0	0.0	0.0	2.7	3.3	0.0
ICAD icad	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LUCD Lucid Diagnostics	1.7965 of 5 stars	3.5	1.0	0.0	0.0	1.1	1.7	0.6
MBOT Microbot Medical	1.5826 of 5 stars	3.5	1.0	0.0	0.0	2.0	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
COCH Envoy Medical	3.00	Buy	$9.25	551.41% Upside
ICAD icad	2.00	Hold	N/A	N/A
LUCD Lucid Diagnostics	3.00	Buy	$3.55	248.04% Upside
MBOT Microbot Medical	3.00	Buy	$9.00	191.26% Upside

Current Analyst Ratings Breakdown

Latest COCH, MBOT, LUCD, and ICAD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/13/2025	LUCD Lucid Diagnostics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$3.00
7/16/2025	LUCD Lucid Diagnostics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$3.00
6/6/2025	LUCD Lucid Diagnostics	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$7.50 ➝ $7.75
5/27/2025	COCH Envoy Medical	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$9.25 ➝ $9.50

(Data available from 8/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
COCH Envoy Medical	$220K	138.90	N/A	N/A	($1.39) per share	-1.02
ICAD icad	$19.61M	5.42	N/A	N/A	$1.08 per share	3.58
LUCD Lucid Diagnostics	$4.36M	25.38	N/A	N/A	($0.43) per share	-2.37
MBOT Microbot Medical	N/A	N/A	N/A	N/A	$0.67 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
COCH Envoy Medical	-$20.80M	-$1.43	N/A	N/A	N/A	-10,961.26%	N/A	-236.14%	N/A
ICAD icad	-$5.62M	-$0.19	N/A	∞	N/A	-26.63%	-15.03%	-11.77%	N/A
LUCD Lucid Diagnostics	-$45.53M	-$1.19	N/A	N/A	N/A	-1,476.35%	N/A	-120.43%	N/A
MBOT Microbot Medical	-$11.44M	-$0.58	N/A	N/A	N/A	N/A	-76.27%	-67.54%	N/A

Latest COCH, MBOT, LUCD, and ICAD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q2 2025	MBOT Microbot Medical	-$0.08	-$0.10	-$0.02	-$0.10	$1.00 million	N/A
7/31/2025	Q2 2025	COCH Envoy Medical	-$0.29	-$0.32	-$0.03	-$0.32	$0.07 million	$0.08 million
5/21/2025	Q1 2025	MBOT Microbot Medical	-$0.15	-$0.08	+$0.07	-$0.08	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
COCH Envoy Medical	N/A	N/A	N/A	N/A	N/A
ICAD icad	N/A	N/A	N/A	N/A	N/A
LUCD Lucid Diagnostics	N/A	N/A	N/A	N/A	N/A
MBOT Microbot Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
COCH Envoy Medical	N/A	0.94	0.74
ICAD icad	N/A	3.66	3.57
LUCD Lucid Diagnostics	N/A	1.15	0.74
MBOT Microbot Medical	N/A	12.06	16.19

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
COCH Envoy Medical	8.59%
ICAD icad	24.61%
LUCD Lucid Diagnostics	74.01%
MBOT Microbot Medical	16.30%

Insider Ownership

Company	Insider Ownership
COCH Envoy Medical	58.90%
ICAD icad	10.29%
LUCD Lucid Diagnostics	6.80%
MBOT Microbot Medical	4.74%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
COCH Envoy Medical	34	21.52 million	8.85 million	Not Optionable
ICAD icad	140	27.47 million	24.64 million	Optionable
LUCD Lucid Diagnostics	70	108.48 million	101.10 million	No Data
MBOT Microbot Medical	20	45.55 million	43.39 million	Optionable

COCH, MBOT, LUCD, and ICAD Headlines

Recent News About These Companies

Microbot Medical (NASDAQ:MBOT) Stock Price Passes Above 200-Day Moving Average After Earnings Miss

August 15 at 12:10 AM | marketbeat.com

Microbot Medical (NASDAQ:MBOT) Stock Price Passes Above 200-Day Moving Average on Disappointing Earnings

August 15 at 2:15 AM | americanbankingnews.com

Microbot Medical (NASDAQ:MBOT) Issues Earnings Results

August 14 at 7:32 PM | marketbeat.com

Microbot Medical (MBOT) Projected to Post Earnings on Wednesday

August 7, 2025 | marketbeat.com

Microbot Medical Secures Grant for Robotic System Development

August 5, 2025 | tipranks.com

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

August 5, 2025 | globenewswire.com

Microbot Medical (NASDAQ:MBOT) Stock Price Crosses Above 200 Day Moving Average - What's Next?

August 2, 2025 | marketbeat.com

Microbot Medical Target of Unusually High Options Trading (NASDAQ:MBOT)

July 31, 2025 | marketbeat.com

Microbot Medical (NASDAQ:MBOT) Stock Passes Above 200-Day Moving Average - Time to Sell?

July 25, 2025 | marketbeat.com

Microbot Medical Appoints New VP of Sales

July 22, 2025 | tipranks.com

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

July 22, 2025 | globenewswire.com

Microbot Medical Boosts Finances with Stock Issuance

July 18, 2025 | msn.com

Microbot Medical Secures China Patent for LIBERTY System, Eyes Q3 2025 US Launch

July 9, 2025 | msn.com

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

July 8, 2025 | globenewswire.com

MBOT - Microbot Medical Inc News - Morningstar

July 3, 2025 | morningstar.comM

MBOT Microbot Medical Inc. - Seeking Alpha

July 2, 2025 | seekingalpha.com

Microbot Medical Joins Russell Microcap Index

June 30, 2025 | tipranks.com

Microbot Medical® Added to the Russell Microcap® Index

June 30, 2025 | globenewswire.com

Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

June 25, 2025 | uk.finance.yahoo.com

Microbot Medical Inc. (MBOT) - Yahoo Finance

June 25, 2025 | finance.yahoo.com

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China Significant Development Suppor

June 18, 2025 | pharmiweb.comP

New MarketBeat Followers Over Time

Media Sentiment Over Time

COCH, MBOT, LUCD, and ICAD Company Descriptions

Envoy Medical NASDAQ:COCH

$1.42 -0.04 (-2.74%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$1.44 +0.02 (+1.06%)

As of 08/15/2025 04:10 PM Eastern

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

icad NASDAQ:ICAD

$3.87 0.00 (0.00%)

As of 07/17/2025

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

Lucid Diagnostics NASDAQ:LUCD

$1.02 +0.04 (+3.96%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$1.01 -0.01 (-0.98%)

As of 08/15/2025 07:56 PM Eastern

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Microbot Medical NASDAQ:MBOT

$3.09 -0.04 (-1.28%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$3.10 +0.01 (+0.16%)

As of 08/15/2025 07:57 PM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time